IK-930 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Nscale’s IPO reveals $140.6m revenue against $1.02bn first-half loss

Anthropic is reportedly considering another advanced Claude model as competition with OpenAI intensifies across enterprise artificial-intelligence workloads. Representative image.

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks is expanding its EOS-based networking platform across 1.6-terabit Ethernet AI fabrics, hyperscale data centers, CloudVision and enterprise connectivity as artificial intelligence reshapes network architecture. Representative image.

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Read More

Pharma Industry News

Ikena Oncology gets FDA fast track designation for IK-930 in mesothelioma

Ikena Oncology has secured fast track designation for IK-930 from the US Food and Drug Administration in the…

June 23, 2022

web analytics